体内CAR-T烈火烹油

蓝鲸财经
03 Jul

文|氨基观察艾伯维再次让市场见识到,体内CAR-T(in vivo CAR-T)的火热。6月30日,艾伯维宣布以21亿美元的高价,收购一家体内CAR-T公司Capstan Therapeutics,后者核心管线尚处于1期临床阶段。同一天,云顶新耀因上周研发日公布的一系列积极进展,其中也包括体内CAR-T,股价逆势大涨8.74%;7月2日,其股价再次上涨,逼进近四年高点。所谓体内CAR-T,指的是...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10